TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT04457076: Evaluation of the Efficacy, Safety, and Tolerability of LevoCept

Sponsor: Sebela Women's Health Inc. · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 1525 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$15,086,080

Rescue Site Savings

+$9,947,384

Unlock Full NCT04457076 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04457076 Rescue Dossier →